Results indicate that IRF4 is expressed at a high level in activated DLBCL, along with a panel of other genes including BATF, LIMD1, CFLAR, PIM2, CCND2, IL16, miR-155, etc (Fig. 2, E and Table S1). This evidence concerns the gene IL16 and diffuse large B-cell lymphoma.